Hints and tips:
Related Special Reports
...To turn to the fund’s remit, it looks to hold companies that “specifically provide products or services to the world’s ageing population”, and this ranges from pharmaceuticals companies to insurers and consumer...
...John Groetelaars, a board member who worked as chief executive at medical technology provider Hillrom until it was acquired by Baxter International last year, took over as interim chief executive following...
...Healthcare and pharmaceutical mergers and acquisitions have more than doubled in 2021 compared with a year ago, when the sector was badly hit by the effects of the pandemic....
...VBI’s chief executive Jeff Baxter said it could be with the regulators for consideration in 12 to 14 months....
...He added that his broad industry experience — including time at Eli Lilly and medical technology company Baxter — would help him “challenge internal thinking”....
...Ian Baxter, who owns Nottingham-based Baxter Freight, said the delays were costing the industry “many millions of pounds every hour”, with his own trucks ensnared in the border chaos carrying clothes destined...
...Dixons Carphone; Fresnillo; Lloyds Banking Group; London Stock Exchange; Metro Bank; Nichols; Persimmon; Reckitt Benckiser; WPP; French Connection; J Sainsbury Thursday Altria; Amazon; American Tower; Baxter...
...Pharmaceutical companies, including Baxter, struggled to supply saline during the recent flu season, while hospitals are also running low on morphine and other injectable painkillers used during surgery....
...A spokesperson for Baxter said: “Assuming available inventory and supply, [our] products are accessible to customers . . . regardless of their purchase of other Baxter products.”...
...Some pharmaceutical groups implemented much larger increases....
...He spent 10 years in sales and marketing at Baxter, a large US drugmaker, before taking a 50 per cent pay cut to become Genzyme’s president in 1983....
...J&J’s condemnation follows several similar interventions by drugmakers such as Pfizer, Roche and Baxter....
...European investors in particular were unfamiliar with the US group spun out of Baxter Health....
...Mr Read also sought to distance Pfizer from other companies that have been broken up in recent years, such as Abbott Laboratories, which spun out its branded drugs business as AbbVie, and Baxter Health,...
...Negotiations were complicated by tax rules related to Baxalta’s spin-off from Baxter....
...“We want a leadership position in rare diseases, which we consider to be one of the most, if not the most, attractive segments of the pharmaceuticals market.”...
...Negotiations have been progressing, the people said, but Shire is still seeking assurances that the tax-free status of Baxalta’s spin-off last year from Baxter, the US medical group, would not be jeopardised...
...HSBC’s pharmaceuticals analysts have been doing some trawling through SEC filings....
...Not if you believe Mr Hantson’s warning in August against a “puzzling” proposal that would deny Baxalta shareholders the long-term benefits of the company’s recent spin-off from Baxter, its former parent...
...Illinois-based Baxalta — spun-off last year from US medical group Baxter — is best known for its treatments for haemophilia, the rare blood disorder, but it also has a presence in immunology and oncology...
...Shire previously believed it would face a prohibitive US tax penalty related to Baxalta’s spin-off from Baxter if it paid with cash....
...Edward Green CEO, Chain Biotechnology Mr Peter George Group Chief Executive, Clinigen Group Dr Peter Pack CEO, Crescendo Biologics Dr Robert Scoffin CEO, Cresset Biomolecular Discovery Dr Anthony Baxter...
...Shire’s offer is all in shares and would give Baxalta shareholders, including Baxter, 37 per cent of the new company....
...Meanwhile, Abbott and Baxter, two diversified US healthcare groups, spun off AbbVie and Baxalta, respectively, as standalone pharma companies....
...Baxter....
International Edition